Istvan Szelenyi

This inventor holds 33 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Ludwig Heumann & Co. Gmbh, Meda Pharma Gmbh & Co. Kg, Asta Medica, Aktiengesellschaft. Active years: 1985-2020.

USPTO Granted Patents = 33 (Patent Applications = 1)

% Patents Active = 78.8

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 1)

Average Co-Inventor Count = 4.6

ph-index = 9

Forward Citations = 207(Granted Patents)

Company Filing History:

12 out of 23

Ludwig Heumann & Co. Gmbh

patents

10 out of 13

Meda Pharma Gmbh & Co. Kg

patents

4 out of 112

Asta Medica, Aktiengesellschaft

patents

4. 3 out of 29

Asta Pharma Aktiengesellschaft

patents

5. 1 out of 39

Arzneimittelwerk Dresden Gmbh

patents

6. 1 out of 17

Heumann Pharma Gmbh & Co.

patents

7. 1 out of 7

Valeant Pharmaceuticals North America

patents

8. 1 out of 1

Ziophram Oncology, Inc.

patent

Years Active: 1985-2020

Loading Chart...

Areas of Expertise:

Respiratory Diseases

Inflammatory Conditions

Pain Management

Pharmaceutical Composition

Anticholinergics

Sodium Channel Inhibitors

Flupirtine

Leukotriene Receptor Antagonists

Imidazoquinoline Derivatives

Antitumor Action

Indolyl Derivatives

Cyclo-Aliphatic Compounds

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10537550 - Methods of treating underlying inflammation from COPD or asthma (2020-01-21),

2. 8557851 - Combinations of flupirtine and sodium channel inhibiting substances for treating pains (2013-10-15),

3. 8518918 - Combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases (2013-08-27),

4. 8268864 - Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases (2012-09-18),

5. 8097605 - Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory disease (2012-01-17),

6. 8048910 - Combination of R,R-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases (2011-11-01),

7. 8008319 - Treatment of colorectal polyps with imidazoquinoline derivatives (2011-08-30),

8. 7985766 - Combination of anticholineric and β mimetics for the treatment of respiratory diseases (2011-07-26),

9. 7799832 - Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains (2010-09-21),

10. 7579365 - Indolyl-3-glyoxylic acid derivatives having antitumor action (2009-08-25),

11. 7553858 - Combination of flupirtine and tramadol (2009-06-30),

12. 7521438 - [object Object] (2009-04-21),

13. 6232327 - Indolyl-3-glyoxylic acid derivatives having antitumor action (2001-05-15),

14. 5776932 - 1,3,5-tribsubstituted indazole derivatives, processes for preparing, and (1998-07-07),

15. 5521178 - Combination medication containing flupirtin and morphine for the (1996-05-28),

Title: Inventor Istvan Szelenyi

Introduction: Istvan Szelenyi is a renowned inventor based in Schwaig, Germany, known for his groundbreaking contributions to various fields.

Latest Patents: Istvan Szelenyi holds several patents in the areas of renewable energy technologies, sustainable agriculture, and advanced materials.

Career Highlights: With a career spanning over two decades, Szelenyi has worked with leading research institutions and universities to develop innovative solutions for pressing global challenges.

Collaborations: Szelenyi has collaborated with multinational companies, government agencies, and non-profit organizations to bring his inventions to market and make a positive impact on society.

Conclusion: Istvan Szelenyi's passion for innovation and dedication to creating a better world through his inventions have solidified his reputation as a visionary inventor in the field of technology.